Manali Petrochemicals Ltd Q2 FY23 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 2
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- India business is growing, with Notedome products holding close to 45% market share in certain high-margin categories and aiming to expand further.
- Penn Globe acquisition adds approximately GBP 16 million to top-line and is expected to sustain or improve EBITDA margins (~22%).
- Specialty chemical contribution targeted to grow from current 6% to around 20%.
- Indian agriculture and food segments expected to experience a CAGR of 12.3% over the next 5 years, driving demand for anti-foaming agents and related products.
- Capacity utilization for Penn Globe is high (85-90%) with plans to explore expansion based on new large customers, especially in the US.
- Manali Petrochemicals aims to expand PG (Propylene Glycol) production by 50,000 tons with Rs. 100 crore investment, projected to improve margins and volumes over 24 months post-clearances.
- Overall growth focus remains on both Indian and overseas markets, leveraging strong market potential in specialty chemicals.
See what Manali Petrochemicals Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
- No specific new fundraising through debt or equity is mentioned in the transcript.
- Financing of the recent acquisition (Penn-White) was done entirely through Manali Petrochemicals Limited's (MPL) own funds.
- Refinancing of the working capital facility will be done with a new asset base lending system.
- Currently, MPL has no long-term debt on its books.
- Cash utilization will be evaluated in the future for expansions and overseas investments before deciding on any shareholder rewards.
- Focus remains on business growth and completing ongoing expansion projects before considering other financial actions.
See what Manali Petrochemicals Ltd management said on order book — free account, 30 seconds.
Capex plans
Yes- Rs. 100 crores approved for Propylene Glycol (PG) expansion of 50,000 tons. (Page 15)
- Focus on completing expansions in India with approvals in advanced stages; construction to start soon. (Page 14)
- Some cash set aside for overseas investments with potential for further opportunities. (Page 14)
- New subsidiary planned: Penn-White India Limited to manufacture specialty products domestically, leveraging lower costs and MPL's R&D. (Page 5)
- Expansion plans dependent on securing large customers, especially in the US; current capacity utilization at 85-90%. (Page 7)
- Emphasis on “Make in India” strategy to increase local manufacturing and reduce supply chain disruptions. (Page 9)
- Sustainability initiatives include developing a new carbon dioxide-based process that may replace fossil fuel raw materials, enhancing margins and environmental benefits upon commercial success. (Pages 15-16)
Track Manali Petrochemicals Ltd — get its next earnings analysis in your feed
Margin guidance
Category 2- Manali Petrochemicals expects EBITDA margins to improve with the planned Propylene Glycol (PG) expansion but did not specify exact forward-looking margin numbers.
- The acquisition of Penn Globe Limited (specialty chemicals) is expected to increase EBITDA margins and generate new product sales, with the aim to sustain or grow its 22% EBITDA margin seen over the last 3 years.
- The PG expansion project is progressing with approvals and expected to complete within 24 months, which should aid revenue growth.
- The specialty chemicals segment’s contribution is targeted to grow from 6% to around 20%, contributing positively to consolidated profitability.
- Company expects business performance to stabilize around pre-COVID operating margins (8%-10% range discussed as a rough benchmark).
- Growth plans are focused on leveraging domestic manufacturing and tapping into the large Indian and Asian markets, supporting long-term earnings growth.
- Management emphasizes growth and stakeholder value creation while keeping cash and expansions balanced.
Order book
How does Manali Petrochemicals Ltd rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does Manali Petrochemicals Ltd rank in Chemicals & Petrochemicals?
Compare Manali Petrochemicals Ltd against every Chemicals & Petrochemicals company (Q2 FY23) on revenue, margins and earnings-call signals.
Continue your research
What Manali Petrochemicals Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Ch. (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF Ltd (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
- Deepak Fertilis. (Q1 FY27)
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…